Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia

Cancer Science

Volumn 104, Issue 10, 2013, Pages 1323-1329

  Wada, Takeyuki ^a,b   Ishimoto, Takatsugu ^c   Seishima, Ryo ^a,b   Tsuchihashi, Kenji ^a   Yoshikawa, Momoko ^a   Oshima, Hiroko ^d   Oshima, Masanobu ^d   Masuko, Takashi ^e   Wright, Nicholas A ^f   Furuhashi, Satoshi ^c   Hirashima, Kotaro ^c   Baba, Hideo ^c   Kitagawa, Yuko ^b   Saya, Hideyuki ^a,g   Nagano, Osamu ^a  

^a Division of Cellular Signaling   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e KINKI UNIVERSITY   (Japan)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN; SALAZOSULFAPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HELICOBACTER FELIS; HUMAN; HUMAN TISSUE; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPASMOLYTIC POLYPEPTIDE EXPRESSING METAPLASIA; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; UPREGULATION;

ADENOCARCINOMA; AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANTIGENS, CD44; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; CYSTINE; DISEASE PROGRESSION; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HUMANS; METAPLASIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM PROTEINS; PEPTIDES; PRECANCEROUS CONDITIONS; PROTEIN ISOFORMS; STOMACH NEOPLASMS; SULFASALAZINE; TUMOR MARKERS, BIOLOGICAL;

EID: 84884975764     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12236     Document Type: Article

References (32)

1. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37.
2. Nomura S, Baxter T, Yamaguchi H et al. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 2004; 127: 582-94.
3. Nozaki K, Ogawa M, Williams JA et al. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology 2008; 134: 511-22.
4. Schmidt PH, Lee JR, Joshi V et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999; 79: 639-46.
5. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004; 23: 1669-78.
6. Tu S, Bhagat G, Cui G et al. Overexpression of interleukin-1β induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008; 14: 408-19.
7. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
8. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003; 4: 33-45.
9. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.
10. Gunthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
11. Fan X, Long A, Goggins M, Fan X, Keeling PW, Kelleher D. Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut 1996; 38: 507-12.
12. Mayer B, Jauch KW, Gunthert U et al. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993; 342: 1019-22.
13. Kuniyasu H, Yasui W, Yokozaki H, Tahara E. Helicobacter pylori infection and carcinogenesis of the stomach. Langenbecks Arch Surg 2000; 385: 69-74.
14. Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993; 341: 725-6.
15. Miwa T, Watanabe A, Yamada Y et al. Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer 1996; 77: 25-9.
16. Ishimoto T, Nagano O, Yae T et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011; 19: 387-400.
17. Nagano O, Okazaki S, Saya H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 2013. doi: 10.1038/onc.2012.638 [Epub ahead of print].
18. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006; 131: 1086-95.
19. Oguma K, Oshima H, Aoki M et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 2008; 27: 1671-81.
20. Weis VG, Sousa JF, Lafleur BJ et al. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression. Gut 2013; 62: 1270-9.
21. + slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci 2010; 101: 673-8.
22. Goldenring JR, Nam KT, Mills JC. The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist. Exp Cell Res 2011; 317: 2759-64.
23. Nomura S, Yamaguchi H, Ogawa M, Wang TC, Lee JR, Goldenring JR. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol 2005; 288: G362-75.
24. Yamaguchi H, Goldenring JR, Kaminishi M, Lee JR. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats. Lab Invest 2002; 82: 1045-52.
25. Goldenring JR, Nomura S. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia. Am J Physiol 2006; 291: G999-1004.
26. Fox JG, Li X, Cahill RJ et al. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996; 110: 155-66.
27. Yae T, Tsuchihashi K, Ishimoto T et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun 2012; 3: 883.
28. Yoshikawa M, Tsuchihashi K, Ishimoto T et al. xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res 2013; 73: 1855-66.
29. Asselman M, Verhulst A, Van Ballegooijen ES, Bangma CH, Verkoelen CF, De Broe ME. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 2005; 68: 71-83.
30. Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 2000; 118: 487-96.
31. Jang TJ, Min SK, Bae JD et al. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 2004; 53: 27-33.
32. Itadani H, Oshima H, Oshima M, Kotani H. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009; 10: 615.